...
机译:人类巨细胞病毒和爱泼斯坦-巴尔病毒感染对新辅助疗法治疗的局部晚期直肠癌患者的18F-FDG PET / CT SUVmax,CT容量和基于KRAS的参数的影响
Department of Radiation Oncology Instituto de Radiomedicina">(1);
School of Medicine Complutense University">(3);
Department of Oncology Hospital General Universitario Gregorio Marañón">(2);
School of Medicine Complutense University">(3);
Institute for Sanitary Research Hospital General Universitario Gregorio Marañón">(5);
Institute of Oncology Hospital Provincial de Castellon">(6);
School of Medicine Cardenal Herrera-CEU University">(7);
School of Medicine Complutense University">(3);
Department of Pathology Hospital General Universitario Gregorio Marañón">(4);
Institute for Sanitary Research Hospital General Universitario Gregorio Marañón">(5);
School of Medicine Complutense University">(3);
Department of Radiology and Medical Physics Hospital General Universitario Gregorio Marañón">(8);
Institute of Oncology Hospital Provincial de Castellon">(6);
Locally advanced rectal cancer; HCMV; EBV; PET/CT toxicity; Long-term outcome;
机译:人类巨细胞病毒和爱泼斯坦-巴尔病毒感染对新辅助疗法治疗的局部晚期直肠癌患者的F-18-FDG PET / CT SUVmax,CT容量和基于KRAS的参数产生影响
机译:VEGFR-2和18F-FDG PET / CT SUVmax预处理评分在预测新辅助疗法治疗的局部晚期直肠癌患者的长期预后中的临床意义
机译:研究了十五种不同的18F-FDG PET / CT定性和定量参数,作为通过新辅助化学放疗治疗的局部晚期直肠癌的病理反应预测指标。
机译:Neoadjuvant在直肠癌中治疗:我们总是需要放射治疗 - 或者我们是否可以更好地评估当地先进的直肠癌?
机译:强烈的Neoadjuvant治疗局部晚期癌症射线=加强Neoadjuvant治疗局部晚期直肠癌
机译:在18F-FDG PET / CT上将肝脏摄取正常的肿瘤SUVmax预测局部晚期直肠癌新辅助放化疗后的病理完全缓解
机译:新辅助同时超分割加速放化疗治疗局部晚期非小细胞肺癌患者的剂量体积参数和重症急性食管炎的预测